A Study to Evaluate Efficacy and Safety of Oxycodone/Naloxone Compared to OxyContin in Korean Cancer Patients
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
Objectives:
To prove non-inferiority of Targin compared to Oxycontin in terms of change of pain intensity
1. Primary objective: Change of pain intensity (NRS 0-10) score (average pain over 24 hours
obtained each evening) within 4 weeks
2. Secondary objectives: Bowel Habit (worsening/no change/improving), Total dose and
frequency of rescue medication, Quality of Life (QOL; EORTC QLQ-C30), Duration to need
of laxative use and Adverse events